Study Protocol
Accepted on 27 Feb 2026
A Phase 1, Single-Center, Randomized, Dose Finding Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Prophylactic COVID-19 pDNA Vaccine After Single Ascending Doses in Healthy Adults: A Study Protocol
in Regulatory Science